• 1 ml Candida parapsilosis e volumine mycelii (lyophil., sterile.) D6

• water for injections
• sodium chloride

Dosage form:
Liquid dilution for injection

Preparation group:
fungal preparation Active

substance:
Candida parapsilosis (lyophil., sterile.) D6

Composition:
1 ml contains: 1 ml Candida parapsilosis (lyophil., sterile.) D6 aquos. dil. (HAB, regulations 5b).

Experience has shown that it is used for:
Registered homeopathic medicinal product, therefore without indication of a therapeutic indication.

Application:
Adults and adolescents from the age of 12 inject 1.0 ml sc twice a week. Pefrakehl® D6 should be discontinued after a maximum of 4 weeks of therapy.

Side effects:
Due to the content of specific organic components in Pefrakehl® D6, hypersensitivity reactions, mainly in the form of skin reactions, can occur in rare cases and an allergy to the component Candida parapsilosis can be triggered. The drug should then be discontinued and a doctor consulted.

Contraindications:
Do not use with:
- Known hypersensitivity to fungi (Candida parapsilosis)
- Children under 12 years of age
- Pregnant and breastfeeding women

Candida parapsilosis, PEFRAKEHL ampoules D 6 Interactions:

Other immunosuppressive drugs can impair the effectiveness of Pefrakehl® D6. An interval of 4 weeks should be observed before and after treatment with orally administered live vaccines.

Precautions:
Not known; see Contraindications.

Additional note Candida parapsilosis, PEFRAKEHL ampoules D 6:

Candida parapsilosis is also contained as an active ingredient in the combination preparation Exmykehl®.

Candida parapsilosis sensu stricto is a common fungal pathogen of low birth weight infants. Together with the less frequently clinically encountered pathogens C. orthopsilosis and C. metapsilosis they compose the C. parapsilosis sensu lato species complex. These yeasts are associated with humans, but typically do not damage individuals with a competent immune system; however, mild to severe manifestations of disease may occur in susceptible patients. Studies presented to date regarding the species complex focus mostly on virulence factors, secreted enzymes, adhesion properties, host receptors and secreted cytokines. This article will review our current knowledge of the C. parapsilosis sensu lato species complex.